Iranian Journal of War and Public Health

eISSN (English): 2980-969X
eISSN (Persian): 2008-2630
pISSN (Persian): 2008-2622
0.5
JMERC
Volume 17, Issue 3 (2025)                   J Clin Care Skill 2025, 17(3): 279-291 | Back to browse issues page

Print XML PDF HTML Full-Text (HTML)


History

How to cite this article
Wennas O, Haji Ghasem Kashani M, Abiri E, Altememy D. Apoptotic Effect of some Schiff's Base Compounds on HepG2 and Adipose Tissue Stem cells. J Clin Care Skill 2025; 17 (3) :279-291
URL: http://ijwph.ir/article-3-85655-en.html
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Rights and permissions
1- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Al-Zahraa University for Women, Karbala, Iraq
2- Department of Cellular and Molecular Biology, Faculty of Biology and Institute of Biological Sciences, Damghan University, Damghan, Iran
3- Department of Pharmaceutics, Faculty of Pharmacy, Al-Zahraa University for Women, Karbala, Iraq
* Corresponding Author Address: Department of Cellular and Molecular Biology, Faculty of Biology and Institute of Biological Sciences, Damghan University, Cheshmeh Ali Street, Damghan, Iran. Postal Code: 3671645667 (kashani@du.ac.ir)
Abstract   (1074 Views)
Aims: Schiff bases are compounds known for their anti-cancer properties. The combination of Schiff bases with metals enhances their anticancer effects. The current study was conducted to determine the apoptotic effect of Schiff base compounds derived from 2-hydroxynaphthaldehyde and 2-chloroethylamine, along with manganese complexes, on HepG2 cells compared to mesenchymal stem cells at the Damghan Faculty of Chemistry, Iran.
Materials & Methods: In this experimental study, three Schiff base compounds, naph-Br, naph(br)2Mn, and naph(br)2Ni, were used to investigate anticancer properties on HepG2 cancer cells and compare them with adipose tissue stem cells. HepG2 and adipose tissue-derived stem cells were treated for 24 hours with these compounds at concentrations of 100, 200, 300, 400, 500, 600, and 700µM. Cell proliferation and survival were evaluated using hemocytometry, MTT, and Ki-67 immunocytochemistry methods.
Findings: Schiff base compounds reduced the proliferation rate of HepG2 cancer cells and adipose tissue-derived stem cells at concentrations of 200, 300, 400, and 500µM, while increasing the rate compared to the control group.
Conclusion: Schiff base compounds inhibit the proliferation of cancer cells and induce apoptosis at multiple concentrations, demonstrating their versatility and efficacy in combating cancer.
 
Keywords: